Woodline Partners »

Bioage Labs shares owned by Woodline Partners

Quarter-by-quarter ownership of Bioage Labs shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Bioage Labs

Tip: Access up to 7 years of quarterly data

All positions including Bioage Labs held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioage Labs by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.6M 125k 20.80

More positions owned by Woodline Partners

Meta Platforms Cl A (META)
Gilead Sciences (GILD)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Asml Holding N V N Y Registry Shs (ASML)
Nuvalent Inc-a (NUVL)
Permian Resources Corp Class A Com (PR)
Encana Corporation (OVV)
Keysight Technologies (KEYS)
Danaher Corporation (DHR)
Aon Shs Cl A (AON)
Stmicroelectronics N V Ny Registry (STM)
Regeneron Pharmaceuticals (REGN)
EQT Corporation (EQT)

View all positions for Woodline Partners

Top funds holding Bioage Labs

AH Capital Management
Sofinnova Ventures
RA Capital Management
OrbiMed Advisors
Sands Capital Ventures
Pivotal bioVenture Partners Investment Advisor
T. Rowe Price Associates
Redpoint Management
Siren
Emerald Advisers
Daniel D. Thurber
Emerald Mutual Fund Advisers, Trust
Citadel Advisors
Jpmorgan Chase & Co
Marshall Wace

View all funds holding Bioage Labs